Pharmacogenomics & Treatment Resistant Depression

09/27/2022

Dr. Brian Forsythe incorporates PGx testing into clinical practice to inform treatment decisions for a treatment resistant depression patient.

02/13/2023

Accelerating patient enrollment with just-in-time trials: TriHealth on the TIME program

The traditional model of activating clinical trials is widely acknowledged as inefficient. The process of establishing a clinical site, negotiating partnerships between sites and sponsors, then attempting to recruit eligible patients in nearby areas can take many months, and it becomes a burden to trial site staff, sponsors, and patients.
Read more
02/09/2023

Real-world data on Measurement Based Care with Tempus PRO™

This real-world data set shows the impact of using Tempus PRO™ to digitally measure patient treatment response.
Read more
12/02/2022

PGx case for ADHD patient (hypothetical)

A hypothetical case study on how insights from the Tempus nP pharmacogenomics report can inform treatment decisions in clinical practice.
Read more